PR: Patent Granted

West Chester, PA, November 30, 2016:

Envera announced today the award of a patent covering a proprietary group of low temperature growing bacteria. The psychrophilic microorganisms are naturally occurring bacteria, isolated from a stream in Pennsylvania, with the ability to grow at 4°C.

Mike Matheny, President and Owner of Envera stated, “The feedback on the performance of these patented strains has been phenomenal. A client of ours obtained excellent results treating a wastewater treatment system that was at 1.7°C, where competitors’ products had failed. This is further validation that Envera’s approach of isolating unique organisms targeted at addressing specific issues results in real world solutions for our customers.” After commenting on the newly patented strains, Mike further elaborated, “We are continuing to build our proprietary microbial collection, and have raised the bar on what it takes to be a top performer in this field.”

The bacteria covered in the awarded patent are listed as Bacillus sp. This decision was made because the bacteria do not match well to any existing species. Genetic analysis using 16S ribosomal RNA indicated the closest matches were Bacillus simplex or Bacillus butanolivorans. Further testing in the laboratory revealed some major biochemical differences between the newly isolated Envera strains, and the Bacillus simplex and Bacillus butanolivorans type strains.

The graph to the right illustrates the metabolic activity of Envera’s Low Temperature Blend (LTB) at 4°C in a respirometer. The data are reported as change in biochemical oxygen demand (BOD). As is shown, Envera’s patented strains quickly germinate, and grow at 4°C, reducing the amount of waste in the system, while the competitive product does not show any metabolic activity.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization, and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, wastewater, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at [email protected] or phone 484-593-4002 for more information.

Chrystine Daly Appointed Vice President of Operations West Chester, PA, August 5, 2016:

Envera announced today the promotion of Chrystine Daly to the position of Vice President of Operations. Chrystine has 16 years of experience in industrial microbiology with an emphasis on the large scale production of beneficial microorganisms.

Chrystine started her career in 2000 as a Fermentation Technologist for Wisconsin BioProducts, where she was involved with the production of yeast and bacteria from shake flask to 10,000 gallon fermentations. This included downstream processing via centrifugation or ultrafiltration and subsequent drying. In 2002, Chrystine moved to Semco BioScience as an R&D Scientist, where she developed new procedures for the fermentation of Bacillus strains. When Semco was sold in 2003, Ms. Daly accepted a position with one of Semco’s clients to establish their laboratory, research protocols, fermentation, and downstream processing systems. Over the next seven years Chrystine held various positions with this company ranging from Fermentation/Laboratory Manager to Technical Sales/International Business Manager. In 2009, Chrystine became Envera’s Technical Services Manager functioning as the liaison between the laboratory and Envera’s clients, handling regulatory affairs, and developing new product formulations. Chrystine also established Envera’s Quality Program, worked with the front office to implement a new order processing system, and took the added responsibility of fermentation process development, large scale fermentation, and the associated downstream processing of microorganisms.

“Chrystine has positively impacted countless areas of our business and has been instrumental in the implementation of many new processes,” said Mike Matheny, President and Owner of Envera. “Her commitment to the development of microbial based alternatives to replace harsh chemicals has been demonstrated throughout her career. She is a great asset and we are very pleased to have her as a member of our Management Team.”

“I am grateful for the new position presented to me,” said Chrystine. “Envera is a company that shows deep commitment and attention to its clientele. This level of respect is carried through to its employees, community, and all other associates. It has been my honor to grow professionally in tandem with this fast growing company.”

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large-scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, wastewater, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology and chemistry.

For more information contact Michael Matheny at [email protected] or visit www.envera.com.

West Chester, PA, July 19, 2016:

Trish Ryan has joined the Envera office staff as the new Customer Service Coordinator. In this role, Ms. Ryan will be working with the sales team, laboratory staff, and office and production personnel to help facilitate a seamless order process for Envera’s clients from order initiation to delivery. Trish holds an Associate’s degree from Montgomery County Community College, and has 10 years’ experience working in quality assurance, sales, and customer service for an international medical technology company.

“I am excited to join a company that is working in the forefront of providing environmentally friendly solutions for industries that used to rely on less eco-friendly options,” said Trish. “I look forward to learning more about this industry and putting my customer service expertise to work for Envera and its clients.”

“We are fortunate to have Trish join our Customer Service team,” said Mike Matheny, President and founder of Envera. “I’m confident she will be an asset not just to Envera’s administrative office, but also to our customers, who will be well-served by her experience and positive personality.”

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large-scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, wastewater, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology and chemistry.

For more information contact Michael Matheny at [email protected] or visit www.envera.com.

Anna Eull Joins Envera as Strategic Account Manager West Chester, PA, October 22, 2015: Envera, a leader in the field of industrial microbiology, with decades of experience in the isolation, selection, production and formulation of microbial cultures, has hired seasoned sales professional, Anna Eull to manage the midwest and west regions of the United States effective today.

Anna received a Bachelor of Science in Bacteriology from the University of Wisconsin-Madison. After graduating Anna held positions as a laboratory researcher including a position at Semco BioScience. While at Semco she was a research and development scientist working on the isolation, identification and characterization of unique bacterial strains. After being promoted to Technical Services Manager she showed diverse project management skills. Her accomplishments included creating a sales database, designing company literature and presentations, as well as being responsible for technical sales support, regulatory issues and the formulation of products.

With several years as a top performing sales representative with Thermo Fisher Scientific, Ms. Eull was responsible for over 150 accounts in a five state territory and exceeded her sales goals every year. She used a combination of laboratory experience and comprehensive product knowledge to quickly assess customer needs and recommend an appropriate solution.

“I am very happy that Anna accepted this position with Envera,” stated Mike Matheny, President and Owner of Envera. He continued, “Her blend of science background, coupled with her excellent customer relationship building skills are a perfect match for our company. Envera is continually looking for ways to add value to our sales department, and we’re excited that Anna brings her talent and scientific knowledge to the company.”

“I look forward to working with an industry leader in the applied science microbiology field. I am enthusiastic about my new role with Envera because it is a strong science-based company that focuses on customer needs.” said Ms. Eull. She will be based in Wisconsin and can be reached at 414-731-6003, or by email at [email protected].

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large-scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, wastewater, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology and chemistry.

For more information contact Michael Matheny at [email protected] or visit www.envera.com.

West Chester, PA, July 27, 2015:

Envera, a leader in the field of industrial microbiology and with decades of experience in the isolation, selection, production and formulation of microbial cultures, has signed a Cooperative Research and Development Agreement (CRADA) with NOAA’s Northeast Fisheries Science Center’s Milford Laboratory in Connecticut to evaluate a newly isolated probiotic strain for potential commercial use in oyster hatcheries. Milford Laboratory conducts research into shellfish culture methods, improving the health of shellfish populations and determining their interactions with the environment.

The use of probiotics in aquaculture as a way to increase the growth of water-based animals has been around for decades. NOAA Laboratory researchers have studied various probiotic strains for their potential usefulness in aquaculture and found that the isolate OY15 was safe to include in feed products for oysters, and in particular, that it improved the survival of growing shellfish larvae exposed to pathogens by 20 to 35 percent.

Employing techniques developed by adapting flow cytometry procedures used in hospitals to analyze human white blood cells, or hemocytes, the Milford Laboratory will assess ten of Envera’s Bacillus strains for their effects on the immune functions of oyster hemocytes. Once the study is complete, Envera will use their expertise to determine if OY15 can be cultured effectively and economically in large-scale production, and then produced in a stable formulation. These two steps are needed to confirm the Milford probiotic strain can move forward with manufacturing and marketing for use by commercial oyster growers. NOAA labs and U.S. industry partnerships like this CRADA with Envera help move new and innovative technologies from the lab to the marketplace.

Mike Matheny, President and Owner of Envera stated, “Envera’s long history in the research and development, and large-scale production of microorganisms, as well as providing stable formulations by freeze-drying or spraydrying, will provide the solid basis required to eventually transfer NOAA’s OY15 isolate for commercial use. We are very excited about this new collaboration.”

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large-scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, wastewater, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology and chemistry.

For more information contact Michael Matheny at [email protected] or visit www.Envera.com.

West Chester, PA, November 21, 2013:

Envera announced today the filing of a patent covering a proprietary group of low temperature growing bacteria. The psychrophilic microorganisms are naturally occurring bacteria, isolated from a stream in Pennsylvania, with the ability to grow at 4°C, and perhaps lower. These strains are expected to be commercially available the first week of December. Mike Matheny, President and Owner of Envera stated, “There are applications, such as waste water treatment, pond maintenance, and soil or seed applications, where our products must work in low temperature environments. The addition of this group of bacteria to our microbial portfolio will greatly increase the breadth of our temperature activity range.” Matheny added, “These strains are also showing promise at temperatures below 4°C.” The bacteria covered in the patent are listed as Bacillus sp. This decision was made because the bacteria did not match well to any existing species. Genetic analysis using 16S ribosomal RNA indicated the closest matches were Bacillus simplex or Bacillus butanolivorans. Further testing in the laboratory revealed some major biochemical differences between the newly described Envera strains and the Bacillus simplex and Bacillus butanolivorans type strains. “I am excited that we may have isolated a new species,” stated co-inventor Dr. Zivile Panaviene. “We are performing additional genetic and biochemical studies to finalize the speciation of these isolates,” added Zivile. “We have 6-12 months of research ahead of us to answer that question, but we are committed to finding the answer,” finished Dr. Panaviene. “Envera is continually isolating and testing new environmental microbial isolates,” commented Matheny. “We have taken this approach because most of the strains in publically accessible culture collections have been extensively tested, and those strains with positive attributes are available to everyone,” added Matheny. “Envera’s approach is to perform our own microbial isolations to build a proprietary culture collection containing unique organisms with extraordinary attributes,” continued Matheny. “Discovering a group of bacteria with exceptional capabilities, and that may be a new species, is further validation of Envera’s business model,” Matheny added. “We are preparing additional patent filings to cover a number of proprietary microbial strains we isolated over the last few years,” concluded Matheny. Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large-scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial- and enzymebased products for the consumer, institutional, agricultural, wastewater and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology and chemistry. Contact: Michael Matheny at [email protected] or phone 484-593-4002 for more information.